| Mastering MRA Monitoring: The Key to Success | 04/14/2025 | |
| Optimizing HF Outcomes Across the Spectrum: Emerging Evidence | 04/16/2025 | |
| Emerging Evidence in HF Care | 04/16/2025 | |
| Nonsteroidal MRAs: The CKD/T1D Potential | 04/16/2025 | |
| Nonsteroidal MRAs: The CKD/T2D Advantage | 04/15/2025 | |
| MOA Deep Dive: The MRA Spectrum | 04/15/2025 | |
| Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care | | |
| When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options | | |
